Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Biotech breakthroughs are reshaping the pharmaceutical landscape, sparking lucrative deals and redefining the future of rare disease treatment. Omeros Corporati...
...
Omeros (OMER) stock catapulted to a 10-month high Wednesday after Novo Nordisk agreed to pay up to $2.1 billion to license its experimental treatment for rare b...
Analyst ratings
59%
of 32 ratingsMore NVO News
(RTTNews) - Omeros Corporation (OMER) surged 148.54% to $10.19, up $6.09, after announcing a $2.1 billion licensing and asset purchase deal with Novo Nordisk fo...
(RTTNews) - Novo Nordisk A/S (NVO), along with Omeros Corp., Wednesday announced a definitive asset purchase and license agreement for the candidate drug zalten...
Novo Nordisk will take over a drug being developed to treat rare blood and kidney disorders from Omeros. tom little/Reuters Novo Nordisk NOVO.B -0.14 %decrease...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
The company is one of two major players in the rapidly growing obesity drug market. Yet, the stock has lost half its value. Danish pharmaceutical giant Novo No...
BMO Capital analyst Evan Seigerman raised the firm’s price target on Novo Nordisk (NVO) to $55 from $50 and keeps a Market Perform rating on the shares ahead of...
Key Points A third-party manufacturing facility has apparently been flagged by the FDA. The plant is owned by pharmaceutical industry peer Novo Nordisk. 10 s...